Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹21 Cr₹16 Cr₹22 Cr₹13 Cr₹75 Cr

What is the latest Contingent Liabilities ratio of GLAND PHARMA ?

The latest Contingent Liabilities ratio of GLAND PHARMA is ₹21 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹21 Cr
Mar2024₹16 Cr
Mar2023₹22 Cr
Mar2022₹13 Cr
Mar2021₹75 Cr

How is Contingent Liabilities of GLAND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹21 Cr
37.24
Mar2024 ₹16 Cr
-29.41
Mar2023 ₹22 Cr
72.94
Mar2022 ₹13 Cr
-82.91
Mar2021 ₹75 Cr -

Compare Contingent Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹31,621.0 Cr -1.9% -5.1% 13.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,862.0 Cr 1.4% 2.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹174,125.0 Cr 7.1% 8.8% 10.3% Stock Analytics
CIPLA ₹125,454.0 Cr 3.9% -1.3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,106.0 Cr -1.3% -1.3% 2.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,263.0 Cr 0.2% -6% -4.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.9%

-5.1%

13.4%

SENSEX

0.1%

0.6%

0.7%


You may also like the below Video Courses